News & Events
News & Events
Dr. Youngmee Jee suggested strategies for Korea-US collaboration at a webinar co-hosted by Yeosijae and the Korean Ministry of Foreign Affairs, titled “Strengthening the Global Rapid Response System for Pandemics”
2021-05-25
Dr. Youngmee Jee, the IPK CEO, suggested strategies for Korea-US collaboration at a webinar co-hosted by Yeosijae and the Korean Ministry of Foreign Affairs, titled “Strengthening the Global Rapid Response System for Pandemics”
On May 14, the IPK CEO, Dr. Youngmee Jee, participated in a webinar held in cooperation by Yeosijae and the Korean Ministry of Foreign Affairs to draw the Korea-US collaboration strategies to strengthen the global response to the pandemic.
Dr. Youngmee Jee (Photo provided by Yeosijae)The webinar, titled “Strengthening the Global Rapid Response System for Pandemics,” gathered leading experts in global health, economics, development, and medicine from the US and South Korea. Along with Dr. Youngmee Jee, CEO of the Institute Pasteur Korea, Dr. Byoung-jo Chun, COO and Chief Economist of Yeosijae, Dr. Yun-Chul Hong, a professor of Preventive Medicine at Seoul National University, participated to share Korean expertise. Ms. Amanda Glassman, Executive Vice President and Senior Fellow at the Center for Global Development, and Dr. Thomas Bollyky, Senior Fellow and Director of the Global Health Program at the Council on Foreign Relations (CFR), joined the discussion from the U.S. side.
Participants suggested various strategies, including enhancing international cooperation for providing equitable access to vaccines and expediting vaccination around the world, strengthening the global surveillance system enabling real-time monitoring, early detection, and information sharing of infectious diseases, and establishing a global fund that can be mobilized immediately in the event of a global health crisis.
Dr. Jee emphasized the importance of expanding the vaccine production capacity of each country and region and said, “We need to collaborate in enhancing vaccine production capacity in Africa where currently are no vaccine production facilities, except in South Africa, and has low vaccination rates. To reinforce the global vaccine production, regional and global supports for the vaccine manufacturers of the DCVMN to produce vaccines approved by the World Health Organization (WHO) are needed.” She added, “WHO pursues to strengthen the effectiveness of the International Health Regulations (IHR) reflecting the experiences of responding to the COVID-19 pandemic, and related discussions in this year's World Health Assembly may yield meaningful results.” “Obligatory the WHO IHR Joint External Evaluation (JEE) and simulation exercise in the future will help strengthen the global infectious disease response and preparedness, including developing countries,” added Dr. Jee.
Go to the story posted by Yeosijae >>
https://en.yeosijae.org/